Curriculum Vitae



Curriculum vitae

BARBARA L. SCHWARTZ

Veterans Affairs Medical Center Phone: (202) 745-8000, ext. 7206

Mental Health Service Line (116A) Fax: (202) 745-8169

50 Irving Street, N.W. E-mail: Barbara.Schwartz@

Washington, D.C. 20422

|EDUCATION |

Ph.D. (l988) University of Toronto, Toronto, Ontario

Experimental Psychology

M.A. (1982) University of Maryland Baltimore County, Baltimore, Maryland

Community Clinical Psychology

B.A. (1978) Pennsylvania State University, University Park, Pennsylvania

Psychology

| Licensure |

Maryland State Board of Examiners of Psychologist; License, No: 03425

|Professional EXPERIENCE |

1980-1981 Graduate research assistant, Laboratory of Clinical Studies

National Institute of Alcohol Abuse and Alcoholism, Rockville MD

1986-present Social Science Analyst, Mental Health Service

Washington DC Veterans Affairs Medical Center (VAMC), Washington DC

1999. Dementia Assessment Clinic, VA Medical Center Satellite Clinic at United States Armed Forces Retirement Home, Washington DC

2008-present Vice Chair, Research & Development Committee, Washington DC VAMC

2011-2014 Director of Research Training for Neuropsychology Postdoctoral Fellowship,

War-Related Illness and Injury Study Center, Washington DC VAMC

|Academic positions |

1998. Assistant Professor, Department of Psychiatry

Georgetown University Medical Center

1998-present Associate Professor, Department of Psychiatry

Georgetown University Medical Center

1998-present Graduate Faculty Member, Interdisciplinary Program in Neuroscience

Georgetown University Medical Center

|VAMC and Academic affiliatE Committees |

1999-2000 Member, Institutional Review Board, Washington DC VAMC

2007-present Member, Research & Development Committee, Washington DC VAMC

2009-present Member, Faculty Development Committee (FDC), Georgetown U. Medical Center

2014-present Member, FDC Mentoring Subcommittee, Georgetown U. Medical Center

2012-present Member, Psychiatry Resident Research Committee, Georgetown U. Medical Center

|Awards |

2003 Essel Investigator, Selected by the Essel Foundation, Research Partners Program

National Alliance for Research on Schizophrenia and Depression

|Patent |

|2002 United States Patent #6,420,404: Herting RL, Schwartz BL, Deutsch SI. "Use of amino-isoxazolidone compounds for improvement of implicit |

|memory" (awarded July 16, 2002). |

|Publications |

Parker E.S., Morihisa J.M., Wyatt R.J., Schwartz B.L., Weingartner H., and Stillman R.C. (l981). The alcohol facilitation effect on memory: A dose response study. Psychopharmacology, 74, 88-92.

Deutsch S.I., Mastropaolo J., Schwartz B.L., Rosse R.B., and Morihisa J.M. (l989). A "glutamatergic hypothesis" of schizophrenia: Rationale for pharmacotherapy with glycine. Clinical Neuropharmacology, 12, 1-13.

Schwartz B.L. (l989). Effects of generation on different measures of indirect memory. Journal of Experimental Psychology: Learning, Memory, and Cognition, 15, 1119-1128.

Rosse R.B., Schwartz B.L., Leighton, M.P., Davis R.E., and Deutsch S.I. (l990). An open-label trial of milacemide in schizophrenia: An NMDA intervention strategy. Clinical Neuropharmacology, 13, 348-354.

Schwartz B.L., Deutsch, L.H., Cohen, C., Warden, D., and Deutsch S.I. (1991). Memory for temporal order in schizophrenia. Biological Psychiatry, 29, 329-339.

Rosse R.B., Schwartz B.L., Davis R.E., and Deutsch S.I. (1991). An NMDA Intervention Strategy in Schizophrenia with "Low-Dose" Milacemide. Clinical Neuropharmacology, 14, 268-272.

Schwartz, B.L., Hashtroudi, S., Herting, R.L., Handerson, H., and Deutsch, S.I. (1991). Glycine prodrug facilitates memory retrieval in humans. Neurology, 41, 1341-1343.

Rosse, R.B., Schwartz, B.L., Mastropaolo, J., Goldberg, R.L., and Deutsch, S.I. (1991). Subtype diagnosis in schizophrenia and its relation to neuropsychological and computerized tomography measures. Biological Psychiatry, 30, 63-72.

Schwartz, B.L. and Hashtroudi, S. (1991). Priming is independent of skill learning. Journal of Experimental Psychology: Learning, Memory, and Cognition, 17, 1177-1187.

Hashtroudi, S., Chrosniak, L., and Schwartz, B.L. (1991). Effects of aging on priming and skill learning. Psychology and Aging, 6, 605-615.

Schwartz, B.L., Hashtroudi, S., Herting, R.L., and Deutsch, S.I. (1992). The effects of milacemide on item and source memory. Clinical Neuropharmacology, 15, 114-119.

Huntzinger, J.A., Rosse, R.B., Schwartz, B.L., Ross, L.A., and Deutsch, S.I. (1992). Clock drawing in the screening assessment of cognitive impairment in an ambulatory care setting: A preliminary report. General Hospital Psychiatry, 14, 142-144.

Rosse, R.B., Schwartz, B.L., Zlotolow, S., Banay-Schwartz, M., Trinidad, A.C., Peace, T.D., Deutsch, S.I. (1992). Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia. Clinical Neuropharmacology, 15, 129-141.

Schwartz, B.L., Rosse, R.B., and Deutsch, S.I. (1992). Toward a neuropsychology of memory in schizophrenia. Psychopharmacology Bulletin, 28, 341-351.

Schwartz, B.L., Rosse, R.B., and Deutsch, S.I. (1993). Limits of the processing view in accounting for dissociations among memory measures in a clinical population. Memory and Cognition, 21, 63 - 72.

Rosse, R.B., Schwartz, B.L., Kim, S.Y., and Deutsch, S.I.(1993). Correlation between antisaccade and Wisconsin Card Sorting Test performance in schizophrenia. American Journal of Psychiatry, 150, 333-335.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Banay-Schwartz, M., Fay-McCarthy, M., and Johri, S.K. (1994). L-tyrosine pharmacotherapy of schizophrenia: preliminary data. Clinical Neuropharmacology, 17, 53-62.

Schwartz, B.L., Rosse, R.B., Veazey, C., and Deutsch, S.I. (1996). Impaired skill learning in schizophrenia: Implications for corticostriatal dysfunction. Biological Psychiatry 39, 241-248.

Schwartz, B.L., Hashtroudi, S., Herting, R.L., Schwartz, P., and Deutsch, S.I. (1996) d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology, 46, 420-424.

Rosse, R.B., Riggs, R.L., Dietrich, A.M., Schwartz, B.L., Deutsch, S.I. (1997). Negative symptoms and cortical atrophy in patients with chronic alcohol dependence. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 280-282.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Fay-McCarthy, M., Rosenberg, P.B., and Fearing, K. (1997). Methylene blue adjuvant therapy of schizophrenia. Clinical Neuropharmacology, 20, 357-363.

Schwartz, B.L., Fay-McCarthy M., Kendrick K, Rosse, R.B., and Deutsch, SI. (1997). Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia. Clinical Neuropharmacology, 20, 364-370.

Deutsch, S.I., Rosse, R.B., and Schwartz, B.L. (1997). Histamine H2 receptor antagonists in schizophrenia: Rationale for use and therapeutic potential. CNS Drugs, 8, 276-284.

Rosse, R.B., Schwartz, B.L., Johri, S., and Deutsch, S.I. (1998). Visual scanning of faces correlates with schizophrenia symptomatology. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 22, 971-979.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Powell, D.G., and Mastropaolo, J. (1999). Stress and a glycinergic intervention interact in the modulation of MK-801-elicited mouse popping behavior. Pharmacology Biochemistry and Behavior, 62(2), 395-398.

Schwartz, B.L., Rosse, R.B., Johri, S., and Deutsch, S.I. (1999). Visual scanning of facial emotions in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 11, 103-106.

Rosenberg, P.B., Rosse, R.B., Schwartz, B.L., and Deutsch, S.I. (2000). Nefazodone in the adjunctive therapy of schizophrenia: An open-label exploratory study. Clinical Neuropharmacology, 23, 222-225.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., and Mastropaolo, J. (2001). A revised excitotoxic hypothesis of schizophrenia: Therapeutic implications. Clinical Neuropharmacology, 24, 43-49.

Drapalski, A.L., Rosse, R.B., Peebles, R.R., Schwartz, B.L., Marvel, C.L., and Deutsch, S.I. (2001). Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication. Clinical Neuropharmacology, 24, 290-294.

Schwartz, B.L., Marvel, C.L., Drapalski, A.L., Rosse, R.B., and Deutsch, S.I. (2002). Configural processing in face recognition in schizophrenia. Journal of Cognitive Neuropsychiatry, 7, 15-39.

Schwartz, B.L., Parker, E.S., Deutsch, S.I., Kaushik, M., & Isaac, A. (2002). Source monitoring in alcoholism. Journal of Clinical and Experimental Neuropsychology, 24, 806-817.

Horsfield, S.A., Rosse, R.B., Tomasino, V., Schwartz, B.L., Mastropaolo, J., & Deutsch S.I. (2002). Fluoxetine’s effects on cognitive performance in patients with traumatic brain injury. The International Journal of Psychiatry in Medicine, 32, 337-344.

Schwartz, B.L., Howard, D.V., Howard, J.H, Jr., Hovaguimian, A., & Deutsch, S.I. (2003). Implicit learning of visuospatial sequences in schizophrenia. Neuropsychology, 17, 517-533.

Deutsch, S.I., Schwartz, B.L., Rosse, R.B., Mastropaolo, J., Marvel, C., & Drapalski, A.L. (2003). Adjuvant topiramate administration: A pharmacological strategy for addressing NMDA receptor hypofunction in schizophrenia. Clinical Neuropharmacology, 26, 199-206.

Marvel, C.L., Schwartz, B.L., & Isaacs, K. (2004). Word production deficits in schizophrenia. Brain & Language, 89(1), 182-191.

Parker, E.S., Landau, S.M., Whipple, S.C., & Schwartz, B.L. (2004). Aging, recall and recognition: Norms for the University of Southern California Repeatable Episodic Memory Test. Journal of Clinical and Experimental Neuropsychology, 26, 428-440.

Marvel, C.L., Schwartz, B.L., & Rosse, R.B. (2004). A quantitative measure of postural sway deficits in schizophrenia. Schizophrenia Research, 68, 363-372.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Weizman, A., Chilton, M., Arnold, D.S., & Mastropaolo, J. (2005). Therapeutic implications of a selective a7 nicotinic receptor abnormality in schizophrenia. Israel Journal of Psychiatry, 42, 33-44.

Soderlund, H., Parker, E.S., Schwartz, B.L. & Tulving, E. (2005). Memory encoding and retrieval on the ascending and descending limbs of the blood alcohol concentration curve. Psychopharmacology (Berl),182(2), 305-17.

Marvel, C.L., Schwartz, B.L., Howard, D.V., & Howard, J.H., Jr. (2005). Implicit learning of non-spatial sequences in schizophrenia. Journal of the International Neuropsychological Society, 11, 659-667.

Schwartz, B.L., Mastropaolo, J., Rosse, R.B., Mathis, G., & Deutsch, S.I. (2006). Imitation of facial expression in schizophrenia, Psychiatry Research, 145, 87-94.

Deutsch SI, Rosse RB, & Schwartz BL. Williams Syndrome: A genetic deletion disorder presenting clues to the biology of sociability and clinical challenges of hypersociability. (2007). CNS Spectrums, 12(12): 903-9.

Deutsch SI, Schwartz BL, Schooler NR, Rosse RB, Mastropaolo J, & Gaskins B. (2008). First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy. Clinical Neuropharmacology, 31, 34-39.

Deutsch SI, Rosse RB, Schwartz BL, Schooler NR, Gaskins BL, Long KD, & Mastropaolo J. (2008). Effects of CDP-Choline and the Combination of CDP-Choline and Galantamine Differ in an Animal Model of Schizophrenia: Development of a Selective α7 Nicotinic Acetylcholine Receptor Agonist Strategy. European Neuropsychopharmacology 18, 147-151.

Henry, J.W., Neptune, D., Chapman, J.C., Schwartz, B.L., Rosse, R.B., & Deutsch, S.I. (2008). The sailor who won’t follow orders. Current Psychiatry 7, 57-61.

Schwartz, B.L., Parker, E.S., Rosse, R.B., Deutsch, S.I. (2009). Recognition memory probes affect what is remembered in schizophrenia. Psychiatry Research 167, 21–27.

Deutsch, S.I., Burket, J.A., Rosse, R.B., & Schwartz, B.L. (2009). Genetic variation of chromosome 1q42: Etiologic mechanism of congenital disorders of neuronal migration and synaptogenesis. Current Psychiatry Reviews 5, 236-249.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Mastropaolo J., Burket, J.A., & Weizman, A. (2010). Regulation of intermittent oscillatory activity of pyramidal cell neurons by GABA inhibitory interneurons is impaired in schizophrenia: Rationale for pharmacotherapeutic GABAergic interventions. The Israel Journal of Psychiatry and Related Sciences. 47(1), 17-26.

Katz, E.U., Burket, J.A., Rosse, S.M., Rosse, R.B., Schwartz, B.L., Deutsch, S.I. (2010). Cerebral ventricular asymmetry and ventriculomegaly interact to increase risk for schizophrenia: A case report and recommendation for routine fetal sonography. CNS Spectrums, 15(9) 522-526.

Schwartz, B.L., Vaidya, C.V., Howard, J.H., Jr., & Deutsch, S.I. (2010). Attention to gaze and emotion in schizophrenia. Neuropsychology. 24(6), 711-720.

Schwartz, B.L., Vaidya, C.V., Shook, D., & Deutsch, S.I. (2013). Neural basis of implicit memory for socio-emotional information in schizophrenia. Psychiatry Research 206 173–180. PMCID: PMC3586761

Deutsch, S.I., Schwartz, B.L., Schooler, N.R., Brown, C.H., Rosse, R.B., & Rosse, S.M. (2013). Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy. Schizophrenia Research, 148, 138–144. PMCID: PMC3732552

Book chapters:

Schwartz, B.L., Hashtroudi, S., Herting, R.L., Fakouhi, T.D., and Deutsch, S.I. The NMDA receptor complex: Enhancement of memory in aging and dementia. In: Basic and Applied Memory: Research on Practical Aspects of Memory, Volume 2. Edited by D. Herrmann, M. Johnson, C. McEvoy, C. Hertzog, and P. Hertel. Hillsdale, NJ:Erlbaum, 1996, 423-437.

Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Gaskins B. NMDA Receptor Hypofunction in Schizophrenia: From mouse to man. In: Focus on Signal Transduction Research, McAlpine G. (ed), New York: Nova Science Publishers, Inc., 2007, pp. 103-122.

Deutsch SI, Schwartz BL, Rosse RB, Mastropaolo J, Fanous AH, Weizman A, Burket JA, Gaskins BL. Schizophrenia endophenotypes as treatment targets. In: Neuropsychiatric Biomarkers, Endophenotypes and Genes: Promises, Advances, and Challenges, Ritsner MS (ed), Springer, pp 113-122, 2009.

Deutsch S., Schwartz B., Urbano M., Burket J., Benson A., Herndon A.: Nicotinic Acetylcholine Receptors in Autism Spectrum Disorders: Therapeutic Implications. In: The Comprehensive Guide to Autism, Patel V., Preedy V., Martin C. (ed.): Springer Reference (). Springer-Verlag Berlin Heidelberg, 2014.

|ABSTRACTS, POSTERS, AND PRESENTATIONS |

Parker E.S., Schoenberg R., Schwartz B.L., and Tulving E. (l983) Memories on the rising and falling blood alcohol curve. Presented at the meeting of the Psychonomic Society, San Diego, California.

Schwartz B.L. (1987). Data driven and conceptually driven processes in priming. Presented at the meeting of the Eastern Psychological Association, Crystal City Arlington, Virginia.

Schwartz B.L., Parker E.S., and Tulving E. (1987). The effects of alcohol and time on different forms of memory. Presented at the meeting of the Society for Neuroscience, New Orleans, Louisiana.

Schwartz B.L., Deutsch L.H., Cohen C., and Deutsch S. I. (1989). Temporal ordering deficits in schizophrenia. Presented at the meeting of the Society for Neuroscience, Phoenix, Arizona.

Schwartz B.L., Hashtroudi S., and Smith, J. (1989). Is priming independent of procedural learning? Presented at the meeting of the Psychonomic Society, Atlanta, Georgia.

Rosse, R.B., Schwartz, B.L., Leighton, M.P., Davis, R.E., and Deutsch, S.I. (1990). Milacemide treatment in schizophrenia. Presented at the meeting of the American Psychiatric Association, New York, New York.

Schwartz, B.L., Rosse, R.B., and Deutsch, S.I. (1990). Implicit memory in schizophrenia. Presented at the meeting of the Society for Neuroscience, St. Louis, Missouri.

Rosse, R.B., Kim, S.Y., Schwartz, B.L., and Deutsch, S.I. (1991). Smooth pursuit eye movement (SPEM) performance improves when tracking target imbedded in an ambiguous figure. Presented at the meeting of the Society of Biological Psychiatry, New Orleans, Louisiana.

Schwartz, B.L., Hashtroudi, S., Herting, R.L., Handerson, H., and Deutsch, S.I. (1991). Glycine prodrug facilitates memory retrieval in humans. Presented at the meeting of the Third International Brain Research Organization (IBRO) World Congress of Neuroscience, Montreal, Canada.

Rosse, R.B., Schwartz, B.L., Kim, S.Y., and Deutsch, S.I. (1992) Correlation between antisaccade and Wisconsin Card Sorting Test Performance in Schizophrenia. Presented at the meeting of the Society of Biological Psychiatry, Washington, DC.

Rosse, R.B., Schwartz, B.L., Risher-Flowers, Peace, T., Veazey, C.R., and Deutsch, S.I. (1992). Evidence of smooth pursuit eye movement and Wisconsin Card Sorting Test impairment in heavy crack cocaine users. Presented at the meeting of the Society of Biological Psychiatry, Washington, DC.

Schwartz, B.L., Rosse, R.B., Veazey, C.R., and Deutsch, S.I. (1992). Motor skill learning deficits in young and older schizophrenic patients. Presented at the meeting of the Society of Biological Psychiatry, Washington, DC.

Rosse, R.B., Schwartz, B.L., and Deutsch, S.I. (1993) Affect recognition performance correlates with oculomotor functioning in schizophrenia. Schizophrenia Research 9(2, 3): 165.

Schwartz, B.L., Rosse, R.B., Epstein, P.D., Friedman, L.A., and Deutsch, S.I. (1993) Memory for temporal order in the list discrimination paradigm in schizophrenia. Schizophrenia Research 9(2, 3): 187.

Schwartz, B.L., Rosse, R.B., Kaushik, M., Herrmann, D., Isaac, A., and Deutsch, S.I. (1994). Visuospatial skill learning and CT correlates in alcoholism. Presented at the meeting of the Society of Biological Psychiatry, Philadelphia, PA.

Schwartz, B.L., Hashtroudi, S., Herting, R.L., Fakouhi, T.D., and Deutsch, S.I. (1994). Glutamatergic drugs enhance memory in older adults and Alzheimer patients. Presented at the meeting of the Third Practical Aspects of Memory Conference, College Park, MD (Session chair).

Schwartz, B.L., Hashtroudi, S. Rosse, R.B. and Deutsch, S.I. (1995). Implicit memory for rotated images in Alzheimer's disease. Presented at the meeting of the Cognitive Neuroscience Society, San Francisco, CA.

Schwartz, B.L., Hashtroudi, S., Herting, R.L., and Deutsch, S.I. (1995). Enhancement of implicit memory in Alzheimer's disease. Presented at the meeting of the Society of Biological Psychiatry, Miami Beach, FL.

Schwartz, B.L., Rosse, R.B., Chwatsky, L., Johri, S., and Deutsch, S.I. (1996). Affect recognition and eye movements for upright and inverted faces in schizophrenia. Presented at the meeting of the Cognitive Neuroscience Society, San Francisco, CA.

Rosse, R.B., Schwartz, B.L., Johri, S., and Deutsch, S.I. (1996). Relation between visual scanning of faces and schizophrenic symptoms. Presented at the Society for Neuroscience, Washington, D.C.

Schwartz, B.L., Fay-McCarthy, Kendrick, K., Rosse, R.B., and Deutsch, S.I. (1997). Effect of nifedipine on motor skill learning in schizophrenia. Presented at the meeting of the International Congress on Schizophrenia Research, Colorado Springs, Colorado.

Fay-McCarthy, Kendrick, K., Rosse, R.B., Peace, T., Wyatt, R.J., and Deutsch, S.I. (1997). The effect of nifedipine on tardive dyskinesia: A double-blind study in eighteen patients. Presented at the meeting of the International Congress on Schizophrenia Research, Colorado Springs, Colorado.

Schwartz, B.L., Rosse, R.B., Powell, D, Johri, S., and Deutsch, S.I. Visual scanning of famous faces in schizophrenia. Presented at the meeting of the American College of Neuropsychopharmacology, Waikoloa, Hawaii.

Rosse, R.B., Schwartz, B.L., Johri, S.K., Retfalvi, and Deutsch, S.I. (1997). Measures of pupillary oscillation in early dementia. Presented at the meeting of the American College of Neuropsychopharmacology, Waikoloa, Hawaii.

Marvel, C.L., Schwartz, B.L., Rosse, R.B., Johri, S., and Deutsch, S.I. (1998). Visual scanning of facial emotions in schizophrenia. Presented at the meeting of the Cognitive Neuroscience Society, San Francisco, CA.

Marvel, C.L., Schwartz, B.L., Rosse, R.B., Johri, S., and Deutsch, S.I. (1998). Role of saccadic eye movements in perceiving configural aspects of face perception. Presented at the meeting of the Society for Neuroscience, Los Angeles, CA.

Schwartz, B.L., Rosse, R.B., Isaac, A., and Deutsch, S.I. (1998). Memory for contextual information in a source memory test in chronic alcoholics. Presented at the meeting of the Society for Neuroscience, Los Angeles, CA.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., and Mastropaolo, J. (1998). Stress alters the efficacy of an NMDA agonist intervention in an animal model of schizophrenia. Presented at the meeting of the American College of Neuropsychopharmacology, Puerto Rico.

Schwartz, B.L., Udebiuwa, A., Rosse, R. B., and Deutsch, S. I. (1999). Selection processes in semantic memory retrieval in schizophrenia. Presented at the meeting of the American College of Neuropsychopharmacology, Acapulco, Mexico (December 14, 1999).

Marvel, C.L., Udebiuwa, A., Thompson-Schill, S.L., Schwartz, B.L. (2000). Verb generation is impaired in schizophrenia. Presented at the meeting of the Cognitive Neuroscience Society, San Francisco, CA (April 11, 2000).

Marvel, C. L., Isaacs, K. L., Schwartz, B. L. (2001). Schizophrenia patients are impaired on a task of word stem completion. Presented at the meeting of the Society for Neuroscience, San Diego, CA (November 11, 2001).

Marvel, C.L., Hovaguimian, A., Schwartz, B.L. (2001). Implicit learning of spatial and non-spatial sequences in schizophrenia. Presented at the Centenary conference of the British Psychological Society, Glasgow, Scotland.

Drapalski, A.L., Marvel, C.L., Schwartz, B.L. (2001). Configural processing in face recognition in schizophrenia patients. Presented at the Centenary Conference of the British Psychological Society, Glasgow, Scotland (March, 2001).

Schwartz, B.L., Hovaguimian, A., Howard, D.V., Howard, J.H., & Deutsch, S.I. (2002) Implicit learning of sequential patterns in schizophrenia. Presented at the Society of Biological Psychiatry conference, Philadelphia, PA.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Marvel, C.L., Dirks, B., & Drapalski, A.L. (2002). Effects of topiramate on clinical and cognitive symptoms in schizophrenia. Presented at the Society of Biological Psychiatry conference, Philadelphia, PA.

Marvel, C.L. & Schwartz, B.L. Impaired word search strategies in schizophrenia. (2002). Presented at the Society of Biological Psychiatry conference, Philadelphia, PA.

Schwartz, B.L., Parker, E.S., Hovaguimian, A., Williams, A., Rosse, R.B., & Deutsch, S.I. (2003). Context-dependent memory impairment in schizophrenia: Analysis of the frontal dysfunction hypothesis. Schizophrenia Research 60(1):182.

Mathis, G., Mangold, K.A., Schwartz, B.L., Mastropaolo, J., Rosse, R.B., & Deutsch, S.I. (2003). The use of a mirror to provide visual feedback for producing emotions. Schizophrenia Research 60(1):146.

Marvel, C., Schwartz, B.L., & Rosse, R.B. (2003). Postural stability in schizophrenia. Schizophrenia Research 60(1):145.

Soderlund, H., Parker, E.S., Schwartz, B.L., & Tulving, E. (2004). Alcohol and memory: New findings with a novel design. Presented at the Canadian Society of Brain Behavior and Cognitive Science 14th Annual meeting, Newfoundland & Labrador, Canada.

Schwartz, B.L., Rowan, M.T., Vaidya, C.J., Howard, J.H., & Deutsch, S.I. (2005). Effects of eye gaze and facial expression on controlled attention in schizophrenia. International Congress on Research on Schizophrenia, April 5, 2005 (Schizophrenia Bulletin 2005; 31(2): 375-376).

Schwartz, B.L., Lazell, M., Williams, H., & Deutsch, S.I. (2005). Implicit learning of letter structure in schizophrenia. Society for Neuroscience 35th Annual Meeting, Washington, DC, November 2005.

Deutsch, S.I., Schwartz, B.L., Schooler, N.R., Rosse, R.B., Mastropaolo, J, & Gaskins, B.L. (2006). Pilot study of an alpha7 nicotinic acetylcholine receptor agonist adjuvant therapeutic strategy for schizophrenia. Presented at the meeting of the American College of Neuropsychopharmacology, December 2006. (Neuropsychopharmacology 2006; 31(Suppl 1): S250)

Deutsch S.I., Schooler NR, Schwartz BL, Rosse RB, Mastropoalo J, Gaskins BL (2007). The Combination of CDP Choline and Galantamine as a Clinical Alpha-7 Nicotinic Acetylcholine Receptor (nAChR) Agonist Intervention in Schizophrenia. International Congress on Schizophrenia Research, Colorado Springs, Colorado, March 30, 2007.

McInerney, K., Schwartz, B.L., Ullrich, L., & Deutsch, S.I. (2007). Probabilistic learning of social cues in schizophrenia. Presented at the meeting of the Cognitive Neuroscience Society, New York, NY. May 7, 2007.

Schwartz, B.L., Shook, D., Vaidya, C.J., & Deutsch, S.I. Repetition priming of facial expressions in schizophrenia: Cognitive and neuroimaging findings. Schizophrenia Bulletin 2009; 35(Suppl 1):242.

Schwartz, B.L., Vaidya, C.J., & Howard, J.H., Jr., & Deutsch, S.I. Implicit learning of socio-affective stimuli in schizophrenia. Presented at the meeting of the American College of Neuropsychopharmacology, Miami Beach, FL, December 8, 2010.

Bansal, S., Rosse, S.M., & Schwartz, B.L. Symptom correlates of a novel antisaccade task in schizophrenia. Presented at the Gordon Research Eye Movement Conference, University of New England, ME, August 2, 2011.

Bansal, S., Rosse, S.M., & Schwartz, B.L. Social avoidance and gaze processing in schizophrenia. Presented at the Society for Neuroscience Conference, Washington DC, November 15, 2011.

Deutsch, S.I. Schooler, N.R., Schwartz, B.L., Rosse, S.M., Brown, C.H., & Rosse, R.B. An intervention to test the alpha7 nicotinic receptor model in schizophrenia: CDP-choline, a cholinergic agonist, and galantamine, a positive allosteric modulator. Presented at the meeting of the American College of Neuropsychopharmacology, Waikoloa, HI, December 5, 2011.

Schwartz, B.L., Deutsch, S.I., Schooler, N.R., Brown, C.H., Rosse, S.M., & Rosse, R.B. The effects of prolonged administration of an alpha7 nicotinic cholinergic agonist intervention on neurocognition in schizophrenia. Presented at the meeting of the American College of Neuropsychopharmacology, Waikoloa, HI, December 5, 2011.

Hull, A., McCoy, K., Adams, A., Kelly, M., & Schwartz, B. Clinical utility and concurrent validity for two measures of social cognition in moderate to severe TBI. Presented at the Society for Social Neuroscience Conference, New Orleans, LA, October 2012.

Adams, A., McCoy, K., Hull, A., Kelly, M., & Schwartz, B. The relationship between facial affect processing and empathy following moderate to severe TBI. Presented at the Society for Social Neuroscience Conference, New Orleans, LA, October 2012.

Lockwood, C., Hull, A., Eickhoff, C., Sullivan, P., Schwartz, B., and Reinhard, M. Cognitive

performance in a VA sample with chronic pain. Presented at the International Neuropsychological Society (INS), Seattle, WA, February, 2014.

Hull, A., Lockwood, C., Eickhoff, C., Schwartz, B., and Reinhard, M. Subjective Cognitive

Dysfunction: Understanding the relationship between self-report of cognitive difficulties,

neurocognitive performance, social and emotional functioning, and pain. Presented at the International Neuropsychological Society (INS), Seattle, WA, February, 2014.

Eickhoff, C., Lockwood, C., Hull, A., Sullivan, P., Schwartz, B., and Reinhard, M. Effect of Impaired

Sleep and Stress on Cognitive Performance in Veterans. Presented at the International Neuropsychological Society (INS), Seattle, WA, February, 2014.

Lockwood, C., McCarron, K., Allen, N., Handel, B., & Schwartz, B. Facial affect recognition in veterans with PTSD. Presented at the International Neuropsychological Society (INS), Seattle, WA, February, 2014.

Allen, N., Lockwood, C., McCarron, K., Handel, B., & Schwartz, B. Exploring the relationship between static and dynamic emotion recognition: A study among US Veterans. Presented at the International Neuropsychological Society (INS), Seattle, WA, February, 2014.

Wong, L.M., Bansal, S., Allen, N. Schwarz, B.L., & Reinhard, M.J. Eye-tracking reveals that veterans with posttraumatic stress disorder avoid looking at faces. Presented at the Society for Biological Psychiatry, New York, NY, May 2014.

Brooks Holliday, S., Lockwood, C. A., Hansen, C., Hull, A., Schwartz, B., & Reinhard, M. Pain, effort, and neuropsychological functioning among veterans with chronic pain. Poster presentation at the American Psychological Association Convention, Washington, DC, August 2014.

Reinhard, M.J., Wong, L.M., Bansal, S., Allen, N., Adams, A.H., & Schwartz, B.L. Inhibitory control and the antisaccade task in Post-Traumatic Stress Disorder: An eye-tracking study. Presented at the Society for Neuroscience, Washington DC, Nov 10, 2014.

Wong, L.M., Bansal, S., Allen, N., Adams, A.H., Schwartz, B.L, & Reinhard, M.J. More than meets the eye: The impact of eye gaze and facial expression on antisaccade performance in PTSD. Presented at the Society for Neuroscience, Washington DC, Nov 10, 2014.

Sacks, S., Schwartz, B.L., Mueser K. A pilot study of the Trauma Recovery Group in Veterans with PTSD and SMI. Presented at the Association for Behavioral and Cognitive Therapies, Philadelphia, PA, November 22, 2014.

|Editorial Experience |

American Journal of Psychiatry (reviewer)

Biological Psychiatry (reviewer)

Brain Research Bulletin (reviewer)

Journal of Clinical and Experimental Neuropsychology (reviewer)

Journal of Psychiatry and Neuroscience (reviewer)

Neuropsychology (reviewer)

PLoS ONE (reviewer)

Psychiatry Research (reviewer)

Psychiatry Research: Neuroimaging (reviewer)

Schizophrenia Research (reviewer)

Book review:

Epilepsy and the Functional Anatomy of the Frontal Lobe (Advances in Neurology, Vol. 66) edited by Herbert H. Jasper, Silvana Riggio, and Patricia S. Goldman-Rakic, NY: Raven Press, 1995 (review published in Neurology 1995;45:1952).

|ExtraMural funding |

Principal Investigator: Exercise Encourages Recovery Trial (ExERT): Exercise-induced Effects on Neurocognition in Schizophrenia. VA Capitol Network (VISN 5) Mental Illness Research, Education, Clinical Center (MIRECC), 4/1/2015-9/30/15

Principal Investigator: Exercise in Schizophrenia: Impact on Cognition and Brain Plasticity. Georgetown-Howard Universities Center for Clinical and Translational Science Pilot and Collaborative Studies Program, 5/14/2013-3/31/2015

Local Site Investigator (PI: Richard Goldberg): A Hybrid Effectiveness-Implementation Trial of a Wellness Self-Management Program, VA HSR&D Cooperative Studies Program. 4/2013-4/2017

Site Co-investigator (PIs: Christine Marx, Ann Rasmusson): A Proof-of-Concept, Double-Blind, Randomized, Placebo-Controlled Study of Ganaxolone in Posttraumatic Stress Disorder. Multicenter study conducted by the PTSD/TBI Clinical Consortium Coordinating Center/ INJURY & TRAUMATIC STRESS (INTRUST) Consortium, 8/2010-3/2014.

Co-Investigator (PI, Richard Rosse): Co-administration of resveratrol and an atypical antipsychotic medication: A drug-drug interaction study. Pilot grant: VA Capitol Network (VISN 5) Mental Illness Research & Education Clinical Center (MIRECC), 1/2011 – 9/2012

Co-Investigator (PI, Stephen Deutsch): Intervention to Test the Alpha 7 Nicotinic Receptor: Eye Movement Risk Markers in Schizophrenia, NIH 3R34MH077849 (Supplement), 9/09-9/12

Co-Investigator (PI, Stephen Deutsch): Intervention to Test the Alpha 7 Nicotinic Receptor, NIH RMH077849A (NIH R34 Clinical Trial Planning Grant), 3/2007-9/2012

Co-Principal Investigator (PI, Matthew Reinhard): Clinical Bio-Behavioral Assessment of Inhibitory Control in PTSD: A Pilot Study of the Anti-Saccade Paradigm. Institute for Clinical Research, Inc., 5/5/11

Principal Investigator: Facial Expressions of Emotion in Schizophrenia: Implicit Processing and Neural Correlates. Independent Investigator Award, National Alliance for Research on Schizophrenia and Depression, 9/03-8/06

Co-Investigator (PI: Stephen Deutsch): AMPA Receptor Antagonism: A Novel Approach to the Treatment of Deficit Symptoms in Schizophrenia. National Alliance for Research on Schizophrenia and Depression, 7/1/00-4/02

Principal Investigator: Implicit Sequence Learning in Schizophrenia; Young Investigator Award, National Alliance for Research on Schizophrenia and Depression, 9/1/99-8/30/00.

Co-Principal Site Investigator (PI: Richard Owen): A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines; VA Health Services Research & Development (HSR&D); 7/5/98-11/00

Co-Investigator (PI, Richard Rosse): Pupillometry in Dementia of the Alzheimer's Type; NINCDS; 10/1/96-9/30/97

Principal Investigator, Evaluation of Cycloserine on Implicit Memory in Alzheimer's Disease. Amendment to protocol NC6-90-02-009: Efficacy and safety of cycloserine in patients with Alzheimer's disease. G.D. Searle, Skokie, Illinois, 1992 - 1993

Principal Investigator, A Double-Blind, Single-Dose Pilot Study Comparing Milacemide 1200 mg with Placebo for Effects on Source Memory and Word Retrieval in Elderly and Young Healthy Subjects. G.D. Searle & Company, Skokie, Illinois, 1989-1990

|MENTORSHIP FUNDING |

Principal investigator and research mentor for Stephanie Sacks, Ph.D., (Trauma Services postdoctoral fellow), Treating PTSD in Special Populations: The Trauma Recovery Group for Veterans with Posttraumatic Stress Disorder and Serious Mental Illness, Institute for Clinical Research, Inc., Washington DC, 2012 – 2013

Principal investigator and research mentor for Kelly McCoy, PsyD. (Neuropsychology postdoctoral fellow), Facial Affect Recognition and Memory in Combat PTSD, Institute for Clinical Research, Inc., Washington DC, 2008-2010

Dissertation chair and sponsor for Cherie Marvel, Implicit Learning of Covariation in Schizophrenia. NIH, F31 MH12207 (pre-doctoral training fellowship), 1999-2001

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download